Aberrant receptor-mediated endocytosis of Schistosoma mansoni glycoproteins on host lipoproteins

PLoS Medicine

Volumn 3, Issue 8, 2006, Pages 1360-1370

  Sprong, Hein ^a   Suchanek, Monika ^b   Van Dijk, Suzanne M ^a   Van Remoortere, Alexandra ^c   Klumperman, Judith ^a   Avram, Diana ^a   Van Der Linden, Joke ^d   Leusen, Jeanette H W ^d   Van Hellemond, Jaap J ^e   Thiele, Christoph ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; GLYCOPROTEIN; GLYCOSYLPHOSPHATIDYLINOSITOL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; HELMINTH PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MEMBRANE ANTIGEN;

ANIMAL CELL; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; CELL VIABILITY; CHRONIC DISEASE; CIRCULATION; CONTROLLED STUDY; ENDOCYTOSIS; HAMSTER; HOST CELL; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; INCUBATION TIME; NEUTROPHIL; NONHUMAN; PROTEIN SECRETION; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; TRYPANOSOMA BRUCEI; ANIMAL; CHO CELL; CRICETULUS; CYTOLOGY; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; ULTRASTRUCTURE;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; ANTIGENS, SURFACE; CHO CELLS; CRICETINAE; CRICETULUS; ENDOCYTOSIS; GLYCOPROTEINS; GLYCOSYLPHOSPHATIDYLINOSITOLS; HELMINTH PROTEINS; HUMANS; LIPOPROTEINS; NEUTROPHILS; RECEPTORS, IGG; RECEPTORS, LDL; SCHISTOSOMA MANSONI; TRYPANOSOMA BRUCEI BRUCEI;

EID: 33748340669     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0030253     Document Type: Article

References (56)

1. Ross AG, Bartley PB, Sleigh AC, Olds GR, Li Y, et al. (2002) Schistosomiasis. N Engl J Med 346: 1212-1220.
2. Pearce EJ, MacDonald AS (2002) The immunobiology of schistosomiasis. Nat Rev Immunol 2: 499-511.
3. Pearce EJ, Sher A (1989) Three major surface antigens of Schistosoma mansoni are linked to the membrane by glycosylphosphatidylinositol. J Immunol 142: 979-984.
4. Sauma SY, Strand M (1990) Identification and characterization of glycosylphosphatidylinositol-linked Schistosoma mansoni adult worm immunogens. Mol Biochem Parasitol 38: 199-209.
5. Ferguson MA (1999) The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research. J Cell Sci 112: 2799-2809.
6. Channe Gowda D (2002) Structure and activity of glycosylphosphatidylinositol anchors of Plasmodium falciparum. Microbes Infect 4: 983-990.
7. Parkin ET, Watt NT, Turner AJ, Hooper NM (2004) Dual mechanisms for shedding of the cellular prion protein. J Biol Chem 279: 11170-11178.
8. Eliakim R, DeSchryver-Kecskemeti K, Nogee L, Stenson WF, Alpers DH (1989) Isolation and characterization of a small intestinal surfactant-like particle containing alkaline phosphatase and other digestive enzymes. J Biol Chem 264: 20614-20619.
9. Denzer K, Kleijmeer MJ, Heijnen HF, Stoorvogel W, Geuze HJ (2000) Exosome: From internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci 113: 3365-3374.
10. Rooney IA, Heuser JE, Atkinson JP (1996) GPI-anchored complement regulatory proteins in seminal plasma. An analysis of their physical condition and the mechanisms of their binding to exogenous cells. J Clin Invest 97: 1675-1686.
11. Rabesandratana H, Toutant JP, Reggio H, Vidal M (1998) Decay-accelerating factor (CD55) and membrane inhibitor of reactive lysis (CD59) are released within exosomes during In vitro maturation of reticulocytes. Blood 91: 2573-2580.
12. Vakeva A, Jauhiainen M, Ehnholm C, Lehto T, Meri S (1994) High-density lipoproteins can act as carriers of glycophosphoinositol lipid-anchored CD59 in human plasma. Immunology 82: 28-33.
13. McCurry KR, Kooyman DL, Alvarado CG, Cotterell AH, Martin MJ, et al. (1995) Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1: 423-427.
14. Anderson SM, Yu G, Giattina M, Miller JL (1996) Intercellular transfer of a glycosylphosphatidylinositol (GPI)-linked protein: Release and uptake of CD4-GPI from recombinant adeno-associated virus-transduced HeLa cells. Proc Natl Acad Sci U S A 93: 5894-5898.
15. Liu T, Li R, Pan T, Liu D, Petersen RB, et al. (2002) Intercellular transfer of the cellular prion protein. J Biol Chem 277: 47671-47678.
16. Onfelt B, Nedvetzki S, Yanagi K, Davis DM (2004) Cutting edge: Membrane nanotubes connect immune cells. J Immunol 173: 1511-1513.
17. Kooyman DL, Byrne GW, McClellan S, Nielsen D, Tone M, et al. (1995) In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium. Science 269: 89-92.
18. Rifkin MR, Landsberger FR (1990) Trypanosome variant surface glycoprotein transfer to target membranes: A model for the pathogenesis of trypanosomiasis. Proc Natl Acad Sci U S A 87: 801-805.
19. Pearce EJ, Hall BF, Sher A (1990) Host-specific evasion of the alternative complement pathway by schistosomes correlates with the presence of a phospholipase C-sensitive surface molecule resembling human decay accelerating factor. J Immunol 144: 2751-2756.
20. Panakova D, Sprong H, Marois E, Thiele C, Eaton S (2005) Lipoprotein particles are required for Hedgehog and Wingless signalling. Nature 435: 58-65.
21. Hall TM, Joseph GT, Strand M (1995) Schistosoma mansoni: Molecular cloning and sequencing of the 200-kDa chemotherapeutic target antigen. Exp Parasitol 80: 242-249.
22. Bergwerff AA, van Dam GJ, Rotmans JP, Deelder AM, Kamerling JP, et al. (1994) The immunologically reactive part of immunopurified circulating anodic antigen from Schistosoma mansoni is a threonine-linked polysaccharide consisting of → 6)-(beta-D-GlcpA-(1 → 3))-beta-D-GalpNAc-(1 → repeating units. J Biol Chem 269: 31510-31517.
23. Deelder AM, van Dam GJ, Kornelis D, Fillie YE, van Zeyl RJ (1996) Schistosoma: Analysis of monoclonal antibodies reactive with the circulating antigens CAA and CCA. Parasitology 112: 21-35.
24. Van der Kleij D, Van Remoortere A, Schuitemaker JH, Kapsenberg ML, Deelder AM, et al. (2002) Triggering of innate immune responses by schistosome egg glycolipids and their carbohydrate epitope GalNAc beta 1-4(Fuc alpha 1-2Fuc alpha 1-3)GlcNAc. J Infect Dis 185: 531-539.
25. Remoortere A, Hokke CH, van Dam GJ, van Die I, Deelder AM, et al. (2000) Various stages of schistosoma express Lewis(x), LacdiNAc, GalNAcbeta1-4 (Fucalpha1-3)GlcNAc and GalNAcbeta1-4(Fucalpha1-2Fucalpha1-3)GlcNAc carbohydrate epitopes: Detection with monoclonal antibodies that are characterized by enzymatically synthesized neoglycoproteins. Glycobiology 10: 601-609.
26. Jansens A, van Duijn E, Braakman I (2002) Coordinated nonvectorial folding in a newly synthesized multidomain protein. Science 298: 2401-2403.
27. Zhang JX, Braakman I, Matlack KE, Helenius A (1997) Quality control in the secretory pathway: the role of calreticulin, calnexin and BiP in the retention of glycoproteins with C-terminal truncations. Mol Biol Cell 8: 1943-1954.
28. Boyum A (1968) Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent. Scand J Clin Lab Invest (Suppl 97): 9-29.
29. Kozarsky KF, Brush HA, Krieger M (1986) Unusual forms of low density lipoprotein receptors in hamster cell mutants with defects in the receptor structural gene. J Cell Biol 102: 1567-1575.
30. Van den Herik-Oudijk IE, Capel PJ, van der Bruggen T, Van de Winkel JG (1995) Identification of signaling motifs within human Fc gamma RIIa and Fc gamma RIIb isoforms. Blood 85: 2202-2211.
31. Sprong H, Degroote S, Claessens T, van Drunen J, Oorschot V, et al. (2001) Glycosphingolipids are required for sorting melanosomal proteins in the Golgi complex. J Cell Biol 155: 369-380.
32. Brouwers JF, Van Hellemond JJ, van Golde LM, Tielens AG (1998) Ether lipids and their possible physiological function in adult Schistosoma mansoni. Mol Biochem Parasitol 96: 49-58.
33. Slot JW, Geuze HJ, Gigengack S, Lienhard GE, James DE (1991) Immunolocalization of the insulin regulatable glucose transporter in brown adipose tissue of the rat. J Cell Biol 113: 123-135.
34. Samuelson JC, Caulfield JP (1982) Loss of covalently labeled glycoproteins and glycolipids from the surface of newly transformed schistosomula of Schistosoma mansoni. J Cell Biol 94: 363-369.
35. Sauma SY, Tanaka TM, Strand M (1991) Selective release of a glycosylphosphatidylinositol-anchored antigen from the surface of Schistosoma mansoni. Mol Biochem Parasitol 46: 73-80.
36. Rodriguez ME, Hellwig SM, Hozbor DF, Leusen J, van der Pol WL, et al. (2001) Fc receptor-mediated immunity against Bordetella pertussis. J Immunol 167: 6545-6551.
37. Dimenstein R, Carvalho VC, Oliveira DN, Gillett MP (1992) Alterations in the levels and lipid composition of plasma lipoproteins (VLDL, LDL and HDL) in Brazilian patients with hepatosplenic schistosomiasis mansoni. Braz J Med Biol Res 25: 1091-1102.
38. Xu X, Caulfield JP (1992) Characterization of human low density lipoprotein binding proteins on the surface of schistosomula of Schistosoma mansoni. Eur J Cell Biol 57: 229-235.
39. Pal A, Hall BS, Nesbeth DN, Field HI, Field MC (2002) Differential endocytic functions of Trypanosoma brucei Rab5 isoforms reveal a glycosylphosphatidylinositol-specific endosomal pathway. J Biol Chem 277: 9529-9539.
40. Fevrier B, Vilette D, Archer F, Loew D, Faigle W, et al. (2004) Cells release prions in association with exosomes. Proc Natl Acad Sci U S A 101: 9683-9688.
41. Sacks D, Sher A (2002) Evasion of innate immunity by parasitic protozoa. Nat Immunol 3: 1041-1047.
42. Borst P, Fairlamb AH (1998) Surface receptors and transporters of Trypanosoma brucei. Annu Rev Microbiol 52: 745-778.
43. Kusel JR, Mackenzie PE, McLaren DJ (1975) The release of membrane antigens into culture by adult Schistosoma mansoni. Parasitology 71: 247-259.
44. Hokke CH, Deelder AM (2001) Schistosome glycoconjugates in host-parasite interplay. Glycoconj J 18: 573-587.
45. Hagan P, Blumenthal UJ, Dunn D, Simpson AJ, Wilkins HA (1991) Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 349: 243-245.
46. Butterworth AE (1994) Human immunity to schistosomes: Some questions. Parasitol Today 10: 378-380.
47. Schild H, Deres K, Wiesmuller KH, Jung G, Rammensee HG (1991) Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells. Eur J Immunol 21: 2649-2654.
48. Ferru I, Rollin C, Estaquier J, Sutton P, Delacre M, et al. (1996) Comparison of the immune response elicited by a free peptide and a lipopeptide construct. Pept Res 9: 136-143.
49. Simon M, Frey H, Gruler H, Bultmann B (1990) Glycolipid storage material in Fabry's disease: A study by electron microscopy, freeze-fracture, and digital image analysis. J Struct Biol 103: 40-47.
50. Pastores GM (1997) Gaucher's Disease. Pathological features. Baillieres Clin Haematol 10: 739-749.
51. Assaad-Khalil SH, Lachine N, Sidrak M, Amara F, Jacotot B, et al. (1992) Immuno-metabolic factors in schistosomal hepatic fibrosis modulating atherogenesis. Ann Biol Clin (Paris) 50: 697-701.
52. Doenhoff MJ, Stanley RG, Griffiths K, Jackson CL (2002) An antiatherogenic effect of Schistosoma mansoni infections in mice associated with a parasite-induced lowering of blood total cholesterol. Parasitology 125: 415-421.
53. Aref S, Refaei ME, Goda T, Sakrana M, El-Nemre H (2004) Accelerated neutrophil apoptosis in neutropenic patients with hepatosplenic schistosomiasis is induced by serum Fas ligand. Hematol J 5: 434-439.
54. Rezende SA, Gollob KJ, Correa-Oliveira R, Goes AM (1998) Down modulation of MHC surface molecules on B cells by suppressive immune complexes obtained from chronic intestinal schistosomiasis patients. Immunol Lett 62: 67-73.
55. Trombetta ES, Mellman I (2005) Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 23: 975-1028.
56. Polacek D, Byrne RE, Scanu AM (1988) Modification of low density lipoproteins by polymorphonuclear cell elastase leads to enhanced uptake by human monocyte-derived macrophages via the low density lipoprotein receptor pathway. J Lipid Res 29: 797-808.